About Intas
Recruitment Fraud Disclaimer:
Intas Pharmaceuticals does not request or accept any fees during recruitment. If someone asks for payment on our behalf, it is a scam. Please report the incident to the local police or cybercrime unit. Your trust and safety are important to us.
Intas is a leading global pharmaceutical company specializing in the development, manufacturing, and marketing of pharmaceutical formulations. The mission of the company is to address unmet medical and societal needs through a fully integrated pharmaceutical value chain spanning across the world.Through its subsidiaries, the International presence of Intas includes the following countries: over 85 worldwide, with some of the more important global markets like North America, Europe, Latin America, and the Asia-Pacific under the well-known brand name Accord Healthcare. The rapid expansion has been due to organic growth and strategic acquisitions alone, vindicating its position in some of the important major pharmaceutical markets across the world.Intas follows high standards of quality, as reflected by products approved for leading global regulatory agencies including USFDA, MHRA, and EMA. Substantial in-house R&D capability, along with the beginning of a focus on highly advanced areas like Biosimilars and New Chemical Entities-Intas continues to push the frontiers of excellence in healthcare.At Intas, our success is fundamentally built on the strength of our people. Our ongoing commitment is to attract and retain the best talent in the industry while fostering an empowering environment that encourages innovation and excellence. This approach ensures that every employee plays a meaningful role in driving both the company’s growth and advancements in global healthcare.Job Title: Executive - ManufactruingJob Requisitions No.: 14361Roles and ResponsibilitesResponsible for In-process production related activities in DP manufacturing, filling, and packing sectionsPreparation of batch manufacturing records, process validation protocol/report of DP area and its associated recordsResponsible for calibration and qualification program of equipment of DP areaExecution and review of IQ, OQ, PQ of equipmentsPerform the Qualification/Verification of equipments and compilation of PV documents of the DP AreaHandling of Equipments and process related to DP manufacturing, filling, and packing sectionsTo manage the product related activity, in absence of primary responsible personTo check and ensure to carry out all the process activities in the plant with compliance of cGMP standards.To ensure safe working conditions, safe operating practices and usage of PPE by all workers and staff.Ensure to identify and resolving engineering issues to keep availability of equipment and utilities as per production planning and thereby ensure zero production loss due to breakdown.Check that all equipments used in area are calibrated, qualified, clean and in good condition for intended use.Ensure to check area, equipment cleanliness & environmental condition before commencement of Manufacturing & packaging of products.Ensure that Manufacturing & Packaging of batches is carried out strictly as per the procedure laid down in respective BPCR/BPRTo ensure availability of consumables, and material issue required for the DP area.To ensure proper utilization of resources with high productivity with zero wastageEnsure to maintain all documents required for regulatory compliance are maintained properly. To check online filling of records and submission to QA department.Qualification RequiredB. Pharm / M. PharmLocation:Plasma Fractionation Unit, Ahm, GJ, IN, 382210Travel: 0%Life at Intas PharmaceuticalsFor over three decades, Intas has thrived due to the exceptional talent of its people. Our growth is fueled by a dynamic environment that nurtures individual potential while fostering collaboration and collective success. We believe that when diverse skills and perspectives unite under a shared purpose and value system, we can achieve remarkable outcomes, driving innovation and excellence across the pharmaceutical landscape.Date: 2 Jul 2025
